Tetrahydrofuran → HCID 66769738, compound

HRID 2193580Notes

Reaction equation

HRID 2193580 reaction equation
[CH3:1][C:2]1[CH:3]=[C:4]([NH:8][C:9]2[N:14]=[CH:13][N:12]=[C:11]([NH:15][C:16]([CH2:21]Br)=[CH:17][C:18]([NH2:20])=O)[CH:10]=2)[CH:5]=[CH:6][CH:7]=1.C(N([CH2:28][CH3:29])CC)C.[C:30]([N:37]1[CH2:42][CH2:41][NH:40][CH2:39][CH2:38]1)([O:32][C:33]([CH3:36])([CH3:35])[CH3:34])=[O:31].[CH2:43]1[CH2:47][O:46][CH2:45][CH2:44]1>>[C:33]([O:32][C:30]([N:37]1[CH2:38][CH2:39][N:40]([CH2:47][CH:43]=[CH:44][C:45](=[O:46])[NH:20][C:18]2[CH:29]=[CH:28][CH:21]=[C:16]([NH:15][C:11]3[CH:10]=[C:9]([NH:8][C:4]4[CH:5]=[CH:6][CH:7]=[C:2]([CH3:1])[CH:3]=4)[N:14]=[CH:13][N:12]=3)[CH:17]=2)[CH2:41][CH2:42]1)=[O:31])([CH3:36])([CH3:35])[CH3:34]

Participants

5

Reactant 4

HCID 8028Tetrahydrofuran2×HCID 8471TriethylamineHCID 143452tert-Butyl piperazine-1-carboxylateHCID 86630628HCID 86630628, compound

Product 1

HCID 66769738HCID 66769738, compound

Procedure

Synthesis of (E)-N-3-(6-[3-methylphenyl]aminopyrimidin-4-yl)aminophenyl-4-piperazinyl-2-butenamide (I-57) To a stirring solution at 0° C. under N2 of N-[3-(6-{3-methylphenyl}amino-pyrimidin-4-ylamino)-4-bromo-2-butenamide (Int-D) (2.15 g, 4.91 mmol) and triethylamine (0.86 mL, 6.17 mmol) in 10 mL of THF was added dropwise a solution of 1-Boc-piperazine (0.92 g, 4.91 mmol) in 10 mL of THF. The solution was allowed to warm to room temperature overnight, was concentrated and was then partitioned between EtOAc and sat. NaHCO3 solution. The organic extract was washed with brine solution, was dried (MgSO4), was filtered and was concentrated to give 2.76 g of 4-{3-[3-(6-{3-methylphenyl}amino-pyrimidin-4-ylamino)-phenylcarbamoyl]-allyl}-piperazine-1-carboxylic acid tert-butyl ester as gummy brown solid. This material was dissolved in 100 mL of CH2Cl2. 20 mL of trifluoroacetic acid was added and the mixture was stirred at room temperature under N2 for 2 h. The mixture was concentrated in vacuo, was basified with sat. NaHCO3 solution and was extracted with EtOAc (2×100 ml). The combined organic extract was dried (MgSO4), was filtered and was concentrated in vacuo. The residue was chromatographed (silica gel, 5% MeOH in CHCl3 [500 mL] then 1% NH4OH-10% MeOH in CHCl3) to give 0.404 g of (E)-N-3-(6-[3-methylphenyl]aminopyrimidin-4-yl)aminophenyl-4-piperazinyl-2-butenamide. (I-57) MS (m/z): 444 (M+1, 100%). 1H NMR (DMSO-d6) δ 10.03 (s, 1H), 9.17 (s, 1H), 9.07 (s, 1H), 8.27 (s, 1H), 7.90 (s, 1H), 7.17-7.36 (m, 6H), 6.79-6.80 (d, 1H), 6.72-6.75 (m, 1H), 6.29 (d, 1H), 6.20 (s, 1H), 3.08-3.39 (m, containing water and ˜3H), 2.70-2.72 (m, 4H), 2.30-2.42 (m, 4H), 2.29 (s, 3H.

Workup

  1. concentrationwas concentrated
  2. customwas then partitioned between EtOAc and sat. NaHCO3 solution
  3. extractionThe organic extract
  4. washwas washed with brine solution
  5. dry with materialwas dried (MgSO4)
  6. filtrationwas filtered
  7. concentrationwas concentrated

Sources & evidence

ORD record
ord-d1a4c019b68b405c9f766974211f91b6
Source dataset
uspto-grants-2012_12
Patent number
US08329901B2

Reaction notes

Loading…